cell lymphoma with a typical latency of 3-4 mo when inoculated into neonatal mice. One of the events observed in M-MuLVinduced disease is the appearance of mink cell focus-forming (MCF) viruses, which result from recombination of the input ecotropic virus with endogenous polytropic retroviral sequences (1, 2) . In mice, MCF proviruses are found in M-MuLVinduced tumors (3-5), and are also observed at significant circulating titres at preleukemic times (6) . They have been proposed to be the "proximal leukemogens" in MuLVinduced disease (7-9) . We have recently reported evidence that MCFs may also play a role early in M-MuLVinduced leukemogenesis, by participating in induction of preleukemic hematopoiesic hyperplasia of the spleen (5, 10) . The proposed role of MCFs in this process was to ' Abbreviations used in this paper. M-and F-MuLV Moloney and Friend murine leukemia virus, respectively ; M-and F-MCF, Moloney and Friend mink cell focus-forming virus, respectively ; FM-MuLV, a molecularly cloned F-MuLV recombinant containing the long terminal repeat of M-MuLV; LTR, long terminal repeat ; Rmcf I and RmcfJ, resistance and sensitivity alleles, respectively, of the Rmcf gene.
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induce suppression of bone marrow hematopoiesis by combined infection with M-MuLV, leading to compensatory extramedullary hematopoiesis in the spleen .
To investigate further the role of MCF viruses in M-MuLVinduced disease, we employed a strain of partially congenic Balb/c mice carrying the resistance allele of the Rmcf gene (Rmcf) developed by Potter et al . (11) . The Rmcf locus was first described by Hartley et al . (9) ; Rmcf mice are resistant to rapid development of Friend MuLV (F-MuLV) induced erythroleukemia (12, 13) . Fibroblast cell cultures derived from certain (Rmcf) strains of mice are resistant to infection by MCFs but not ecotropic MuLVs (9, 14) . Resistance is correlated with cell surface expression of an endogenous MCFrelated gp70 (SU) protein (12) (13) (14) (15) . It has been hypothesized that expression of this protein in Rmcf mice interferes with spread of in vivo-generated MCFs due to blockage of MCF receptors by the endogenous MCF-related gp70. Indeed, MCFs propagate poorly or not at all in Rmcf mice inoculated with F-MuLV (12, 13) . The Rmcf gene may code for the MCFrelated gp70 (16) or, alternatively, for a gene affecting expression of endogenous MuLV-related proviruses (16, 17) .
In the experiments described in this report, we tested the effects of M-MuLV in Rmcf mice. Since Friend and Moloney MCFs share the same receptor as measured in interference assays (18) , it seemed likely that Rmcf mice would be resistant to in vivo-generation of M-MCF and that they would be relatively resistant to M-MuLV-induced leukemia . Moreover, MCF-driven preleukemic events might not occur in M-MuLVinfected Rmcf animals. We report here that there is significantly less restriction for M-MuLV leukemogenesis and MCF generation and propagation in Rmcf mice than is the case for F-MuLV-inoculated Rmcf mice and that the difference is governed by the LTR. A model to explain this difference is presented .
Materials and Methods
Viruses and Cell Lines. Generation ofa molecularly cloned viral stock of M-MuLV was described previously (19) . For M-MCF, either Mo-MCF,-1 or MCFMoLTR viral stock was used . Mo-MCF,-1 contains only one copy of the 75-bp direct repeat of the M-MuLV enhancer (20) while MCFMoLTR contains two direct repeats . MCFMoLTR was generated by molecular cloning in which the Xho I-Cla I fragment of the M-MCF, genome (1 .5 kb to 7 .6 kb on the proviral map, encompassing the 3' half of gag, all of pol, and the SU portion of env) was exchanged at the same sites into an infectious M-MuLV provirus clone . Infectious virus was then recovered by transfection of the MCFMoLTR clone into NIH-3T3 cells. Pathology data reported in Fig. I are that of MCFMoLTR. The F-MuLV and F-MCF producer cell lines were the kind gift of Sandra Ruscetti (NIH, Bethesda, MD) (12) . FM-MuLV (21) was kindly provided by Nancy Hopkins (MIT, Cambridge, MA). Pseudotypic viral stocks were obtained by superinfection of cells producing one MuLV with an MuLV ofa different interference group. Viral titers ranged from 10^to 106 infectious U/ml as determined by reverse transcriptase assay (for pseudotypic mixtures) (22) or UV/XC assay (23) (for ecotropic virus alone). All cells were grown in DMEM plus 10% calf serum .
Inoculation ofMice. Partially congenic Balb/c mice carrying the resistance allele of the Rmcf gene (CxD2) (11, 16) were the generous gift of Sandra Ruscetti. These mice were interbred after the 5th generation backcross of (DBA/2 x Balb/cAnPt)F, x Balb/cAnPt (16) . Neonatal CxD2 (Rmcf) or Balb/cAnPt (Rmcf) mice were inoculated intraperitoneally with 0.2 ml viral supernatant and sacrificed when moribund .
Southern Blot Analysis. DNA was obtained from tumor splenocytes and thymocytes as described previously (24, 25) . Southern blot procedures were performed using Gene Screen Plus (New England Nuclear, Boston, MA), hybridized in 50% deionized formamide, 1% SDS, 1 M NaCl, 10% dextran sulfate at 42°C, followed by two 30 washes at 65°C in 1xSSC + 1% SDS and two 30 washes at room temperature in 0 .1 x SSC according to manufacturer's specifications. Blots were then exposed to Kodak XAR-5 film at -80°C. Fragments used for P'2-labeled random primer probes were as follows : the 700-bp Bam HI-Eco RI fragment from M-MCF,-1 (20); the x+400-bp Ava I-Eco RI fragment from the F-MCF Clavaco clone (kindly provided by Alan OlifF, Merck and Co ., Rahway, NJ) (26) ; the 8 .2-kb Eco RI fragment including the entire 1-LTR permuted F-MuLV genome from F-MuLV Clone 57 (27) ; the 600-bp Eco RI fragment from 86T5 (28), a cDNA clone for the T cell receptor (3 chain locus . Moribund mice all exhibited enlarged thymus, spleen, and lymph nodes as described previously for M-MuLV-inoculated NFS and NIH Swiss mice (19, 29) .
The unexpected sensitivity of the Rmcf mice to M-MuLV leukemogenesis raised the possibility that these mice no longer carried the Rmcf allele . Therefore, we also inoculated (CXD2) (Rmcf) and Balb/c (Rmcf) mice with F-MuLV . As shown in Fig. 1 , lower panel, F-MuLVinoculated Rmcf mice exhibited an average time to death of 9 wk with 100% dying by 19 wk, whereas 50% of the Rmcf mice were still living at 37 wk . These results were consistent with those observed by others previously for Rmcf and Rmcf mice (13, 16) , and confirmed that our CxD2 mice still contained the Rmcf allele. Thus, M-MuLV disease is not subject to restriction by the Rmcf allele in the Rmcf mice used in these experiments, while F-MuLV disease is.
M-MCF Generation and Propagation in Rmcf Mice. Since F-MCF was previously shown to propagate poorly or not at all in F-MuLV-inoculated Rmcf mice (12, 13), it was important to determine if the lack of Rmcf restriction for M-MuLV pathogenesis was associated with a lack of restriction for M-MCF propagation . We tested for the presence of M-MCFs in M-MuLV-induced tumors from Rmcf mice by Southern blot analysis as shown in Fig. 2 A . An M-MCF provirus resulting from recombination between the input ecotropic M-MuLV and endogenous polytropic sequences would contain a Bam HI site derived from the polytropic genome at the 5' end of the MCF env region and retain the Xba I site in the 3' LTR of the M-MuLV parent . Therefore, digestion of DNA with Bam HI plus Xba I will yield a unique diagnostic 2 .3-kb fragment hybridizable with an HCF env probe if an M-MCF provirus is present (5) . As shown in TableJ The presence of F-MCFs in Rmcf mice has been investigated in previous reports by infectious center assays or by immunoprecipitation of a gPr 80 MCF envelope polyprotein precursor (12, 13, 16) , and the results were negative. It was important to compare the sensitivity of the results obtained by the previous assays with the Southern blot analyses for MCF provirus in Fig. 2 . Therefore, we examined Rmcf tumors induced by F-MuLV after long latency for the presence of F-MCF. For detection of F-MCF, Eco RI digestion will yield a diagnostic 3.5-kb fragment spanning the pol and env regions which hybridizes with an F-MCF probe. As seen in Fig. 2 C, F-MuLV-induced tumors in CxD2 mice showed no evidence for MCFs, even though F-MuLV provirus was easily detected by separate Southern analysis using an F-MuLV probe (data not shown) . Thus, the Southern blot assay was in agreement with previous assays, and the results for Fig . 2 indicated that M-MCF formation and propagation is not restricted to the same extent as for F-MCFs in Rmcf mice. We also examined three tumors induced in Balb/c (Rmcf) mice inoculated with F-MuLV. All contained F-MCF provirus (Fig. 2 D) . These results indicated that failure of F-MCF to generate or propagate in CxD2 mice was due to the Rmcf allele of the Rmcf gene, as reported . Furthermore, the Rmcf allele may also have provided slight resistance to spread of M-MCF, since one M-MuLV induced tumor in CxD2 mice failed to show evidence by this analysis of MCF proviruses .
Genomic Sequences Requiredfor Propagation ofM-MCF. The ability of M-MCFs to propagate in Rmcf mice in contrast to F-MCFs was quite striking . We wished to determine the regions of the M-MuLV and F-MuLV responsible for the differential generation and/or propagation of the corresponding MCFs in Rmcf mice. Even though M-MCF and F-MCF are of the same receptor-binding class with respect to NIH-3T3 fibroblasts (18) , it was formally possible that the M-MCF and F-MCF envelope glycoproteins bind MCF receptor(s) with different affinities such that M-MCF is not subject to superinfection resistance by the endogenous MCF-related gp70 on Rmcf cells, while F-MCF is . Alternatively, the differing behaviors of F-MCF and M-MCF in -Rmcf mice could result from differences in LTR enhancer activities. The different pathogenic specificities of F-MuLV and M-MuLV have been mapped to the enhancers in the LTRs (21) . To test these hypotheses, we made use of a molecularly cloned recombinant between M-MuLV and F-MuLV, FM-MuLV (30). FM-MuLV contains the U3-R region of the M-MuLV LTR (including the enhancers and promoter) with the remainder of the genome derived from F-MuLV . FM-MuLV induces T lymphoid leukemia, due to the presence of the M-MuLV enhancers (30, 31) . FM-MuLV was inoculated into CXD2 and Balb/c neonatal mice, and the results are shown in Fig. 3 . The time course of disease did not vary significantly for FM-MuLV inoculated into Rmcf versus Rmcf mice as seen in Fig. 3 and, in fact, was similar to that seen for wild-type M-MuLVinoculated mice. All moribund mice displayed gross pathology typical of M-MuLVinduced T lymphoma, as described above. In addition, T cell receptor beta chain analysis (24, 32) confirmed that tumor cells were of T cell origin (Fig. 4) (Fig. 2) , since the FM-MCF would contain the Xba I site in the M-MuLV LTR and the Bam HI site is present in the MCF-specific env sequences introduced in the recombination event . (12) . However, the potential effect of such a pseudotypic mixture on F-MuLVinduced disease of longer latency has not been investigated . We inoculated neonatal CxD2 mice with a pseudotypic mixture of either F-MuLV/F-MCF or M-MuLV/ M-MCF. Slight acceleration by M-MCF of M-MuLVinduced disease (2-3 wk) was observed in CxD2 mice (Fig . 1, upper   393 Brightman et al . To interpret these results, it is important to consider that at early times, most MCF particles probably also have MCF envelope proteins, i.e., pseudotyping of MCF genomes with ecotropic env proteins is probably rare due to the low multiplicities of infection in vivo at this time . (Fig . 6 A) . MCP propagators could be either hematopoietic or non-hematopoietic cells.
The in vitro experiments suggest that many of these have surface MCP receptors (9, 15, 16) (Fig. 6B, upper panel) . If all potential F-MCF propagators are expressing endogenous MCF gp70 in Rmcf mice, they would be blocked for F-MCF infection (Fig . 6 B Fig . 6 . These investigators showed that expression of endogenous MCF-like gp70 in Rmcf mice is found predominantly on erythroid cells and to a lesser extent on myeloid and lymphoid progenitors . Notably, 90-95% of Rmcf mouse thymocytes do not express the endogenous gp70.
While the Rmcf gene did not delay the time course of leukemogenesis for M-MuLV or FM-MuLV in CxD2 mice, there may have been slight blockage in MCF formation, since one tumor did not show evidence for MCFs. According to our model, it is quite likely that some M-MCF propagator cells are blocked in Rmcf mice (e .g., myeloid cells) . Thus, a decrease in efficiency of MCF formation and propagation for M-MuLV and FM-MuLV in CXD2 mice would be reasonable .
As shown in Fig. 1 , lower panel, a pseudotypic mixture of F-MuLV/F-MCF showed greatly accelerated disease in comparison to F-MuLV alone in Rmcf mice . Two aspects require explanation . First, the fact that the F-MCF accelerated the disease implies that it had an effect in vivo, even in Rmcf mice. However, since the F-MCF was administered as a pseudotypic mixture with F-MuLV, F-MCF genomes could infect cells by way of ecotropic F-MuLV glycoprotein and
